It swallowed a big rival, the cost savings are showing up ahead of schedule, and the debt keeps shrinking. Wall Street still prices it like a dry well.
Nov 6, 2026
•
6 min read
The company behind the card reader at your coffee shop just doubled its cost-cutting goal and queued up a buyback. The price tag still looks like a typo.
Nov 4, 2026
Profitable, opening stores at a record clip and buying back stock, yet the market just marked it down like day-old bread. Time to check the clearance aisle.
Nov 2, 2026
This company owns some of the Strip’s biggest casinos, its biggest tenant is still paying rent, and the board just cleared it to bet on itself. Wall Street won’t play.
Oct 30, 2026
Venmo is humming, the share count keeps shrinking, and profit per share just beat the company’s own plan. The checkout button still takes the blame.
Oct 28, 2026
Hyperscalers cannot run new data centers on batteries alone. The largest supplier of the bridge fuel just got meaningfully larger. That is your opportunity.
Oct 26, 2026
Worried about used car prices? Here is the retailer already priced as though your worst case has arrived, with earnings days away.
Oct 23, 2026
Most companies announce a transformation, and the shares drop. This one closed up 6% on Monday, which still looks light.
Oct 21, 2026
5 min read
Wholesale used-car prices have softened, and the market has decided this lender was collateral damage. Tomorrow morning it gets to answer.
Oct 19, 2026
A chipmaker took about 530 megawatts of its capacity on a fifteen-year deal, with room to expand. The stock still just printed a fresh low.
Oct 16, 2026
8 min read
The drug company people worry about losing faces generic rivals as early as April 2028. The newer products already make up most of the revenue.
Oct 14, 2026
Restaurant fries come from somewhere, and one of the biggest suppliers just beat, raised guidance, and still pays you over three percent to hold it.
Oct 12, 2026
Everyone is sure AI will gut this industry. Meanwhile, the company is cutting $1.5 billion in costs and paying you over 4% to be patient.
Oct 9, 2026
9 min read
Four billion dollars changed hands last month and the share price barely blinked. The acreage behind that deal is about to start showing up in the numbers.
Oct 7, 2026
Some children with heart defects need repeat open-heart surgery as they grow. One company just won approval for a valve designed to expand as they grow.
Oct 5, 2026
Most companies control their own profits. This one leaves it to a government score it can push on but cannot decide.
Oct 2, 2026
You have four or five of their products in a cupboard right now. The stock trades at roughly 60% of the business's value. Here is the number that matters tomorrow.
Sep 30, 2026
High car prices and high loan rates have crushed demand. The company's leadership has responded by buying shares, not selling them.
Sep 28, 2026
Most endorsement deals are a cheque and a photo shoot. This one handed the athlete equity, so he now needs the share price to work too.
Sep 25, 2026
Three separate board members bought shares within five days of each other. Then an activist investor showed up demanding the CEO be replaced.
Sep 23, 2026
7 min read
A cancer trial worked in most patients and fell short in one smaller group. That nuance got flattened into a single ugly day of selling.
Sep 21, 2026
This travel software stock grew revenue 38% and cut its loss nearly in half. Now management expects another 30% growth quarter.
Sep 18, 2026
When a takeout gets announced at double the price, the gap usually vanishes within days. This one has not entirely. See why that remaining sliver is worth a look.
Sep 16, 2026
Revenue has taken a hit from a major business transition, but recurring cash flow has been moving in the opposite direction. The next few quarters could expose the gap.
Sep 14, 2026
Two years of volume pressure have beaten this grocery stock down. You do not need a turnaround for the math to start looking very different.
Sep 11, 2026
